Výsledky vyhledávání - "Chen-liang Guo"

First report of the invasion of Q2 subclade of Bemisia tabaci MED in South Korea as revealed by extensive field investigation

Autor: Yong-zhe Zhu, In-hong Jeong, Chen-liang Guo, Dong Chu

Publikováno v: Phytoparasitica. 50:91-100

The genetic structure analysis of alien species may be associated with the introduction routes and potential mechanism of invasions. There were at least three introduced cryptic species of Bemisia tabaci (MEAM1, MED, and JpL) determined in South Kore

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2261843b8fd2bf71479f5e7fc01a993
https://doi.org/10.1007/s12600-021-00946-4

Zobrazit plný text záznamu

First evidence for thermal tolerance benefits of the bacterial symbiont Cardinium in an invasive whitefly, Bemisia tabaci

Autor: Meng-Ying Yuan, Chen-liang Guo, Kun Yang, Youjun Zhang, Dong Chu, Tong-Xian Liu, Ying Liu

Publikováno v: Pest Management Science. 77:5021-5031

Backgroud Cardinium symbiont is a maternally inherited bacterial endosymbiont and widely spreads in arthropods including Bemisia tabaci (Hemiptera: Aleyrodidae). However, the potential role of Cardinium played in the biology of their hosts is largely

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89b831a6ada0eefc335e67b99641c8f7
https://doi.org/10.1002/ps.6543

Zobrazit plný text záznamu

Invasion Biology and Management of Sweetpotato Whitefly (Hemiptera: Aleyrodidae) in China

Autor: Youjun Zhang, Michael A. Keller, Chen-liang Guo, Yong-zhe Zhu, Dong Chu, Tong-Xian Liu

Publikováno v: Journal of Integrated Pest Management. 12

The sweetpotato whitefly, Bemisia tabaci Gennadius (Hemiptera: Aleyrodidae), is a broadly invasive pest of great economic significance to agricultural and horticultural systems in the world. Bemisia tabaci contains more than 44 cryptic species, among

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b5587177f32ffc8ab987af03e77c87a
https://doi.org/10.1093/jipm/pmaa024

Zobrazit plný text záznamu

The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8

Autor: Chen-liang Guo, Jia-jie Shi, Si-meng Chen, Yi Xue Li, Linghua Meng, Jian Ding

Publikováno v: Acta pharmacologica Sinica. 39(8)

Tamoxifen, an important endocrine therapeutic agent, is widely used for the treatment of estrogen receptor positive (ER(+)) breast cancer. However, de novo or acquired resistance prevents patients from benefitting from endocrine approaches and necess

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::378f40f201a21e125a4cfe5147e61867
https://pubmed.ncbi.nlm.nih.gov/29345254

Zobrazit plný text záznamu

HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer

Autor: Chen-liang Guo, Jia-jie Shi, Si-meng Chen, Yi Su, Linghua Meng, Yi Chen, Shen Yanyan, Yi-chao Xu, Jian Ding

Publikováno v: International Journal of Cancer. 135:2462-2474

mTOR inhibition led to activation of upstream receptor tyrosine kinases (RTKs) and AKT, which may attenuate the efficacy of mTOR kinase inhibitors. We sought to discover efficient drug combination with mTOR inhibitors by elucidating the survival feed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::735e6d20dd0a5ac8f8281e5f183b1418
https://doi.org/10.1002/ijc.28880

Zobrazit plný text záznamu

DW09849, a Selective Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Prevents PI3K Signaling and Preferentially Inhibits Proliferation of Cells Containing the Oncogenic Mutation p110α (H1047R)

Autor: Xi Zhang, Chen-liang Guo, Jia-li Liu, Guo-Rui Gao, Xiang Wang, Jian Ding, Sufen Cao, Linghua Meng, Wenhu Duan, Linjiang Tong

Publikováno v: Journal of Pharmacology and Experimental Therapeutics. 348:432-441

Phosphatidylinositol 3-kinase, α isoform (PI3Kα) plays essential roles in cell metabolism, growth, and proliferation and has been validated as a promising anticancer target. In an effort to search for new PI3Kα-selective inhibitors, DW series comp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b78949c9e9eb61afd5d3236ce570202f
https://doi.org/10.1124/jpet.113.210724

Zobrazit plný text záznamu

HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer

Autor: Si-Meng, Chen, Chen-Liang, Guo, Jia-Jie, Shi, Yi-Chao, Xu, Yi, Chen, Yan-Yan, Shen, Yi, Su, Jian, Ding, Ling-Hua, Meng

Publikováno v: International journal of cancer. 135(10)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7014f8212f5707722939f77d8ab37b5b
https://pubmed.ncbi.nlm.nih.gov/31997398

Zobrazit plný text záznamu

Abstract 909: Hsp90 inhibitor AUY922 abrogates mTOR inhibitor AZD8055-induced up-regulation of HER2/HER3 and potentiates antiproliferative activity in human breast cancer cells

Autor: Chen-liang Guo, Linghua Meng, Si-meng Chen, Jian Ding

Publikováno v: Cancer Research. 73:909-909

Mammalian target of rapamycin (mTOR) has been validated as a promising target for cancer therapy. Several mTOR kinase inhibitors displaying potent antitumor activity due to their capability to inhibit both mTORC1 and mTORC2 have entered clinical tria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b443d3b379dbf21e0bdddefde176b861
https://doi.org/10.1158/1538-7445.am2013-909

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání